preloader

1065(E)

(Published in Part II, Section 3, Sub Section (ii) of the
Gazette of India Extraordinary, dated the 11th July, 2006)

Government of India
Ministry of Chemicals and Fertilizers
(National Pharmaceuticals Pricing Authority)

                                                                New Delhi, the 11th July, 2006

ORDER

S.O.1065(E)  – In exercise of the powers, conferred by sub-paragraphs (1) and (2) of paragraph 9 and paragraph 11 of the Drugs (Prices Control) Order, 1995, read with No. S.O. 637 (E) dated the 4th September, 1997 issued by the Government of India in the Ministry of Chemicals and Fertilizers, the National Pharmaceutical Pricing Authority, hereby fixes the prices as specified in column (5) of the table below as ceiling prices exclusive of excise duty and local tax, if any, of each of the Scheduled formulations specified in the corresponding entry in column (2) of the said Table with the strength and pack size specified respectively in the corresponding entries in columns (3) and (4) thereof:

TABLE

Sl. No. Name of the Formulation Strength Pack Size Ceiling Price (Rs.)
(1) (2) (3) (4) (5)

--

Each tab contains

--

1 Salbutamol + Etophylline Tablets Salbutamol Sulphate eq. to
Salbutamol -4mg
Etophylline 200mg
10’s Strip/Blister 3.68
2 Salbutamol+ Ambroxol+
Guaiphenesin Tablets
Salbutamol Sulphate eq. to
Salbutamol 2mg
Ambroxol HCL 15mg
Guaiphenesin 100mg
10’s Strip/Blister 3.04

--

Each cap contains

--

3 Salbutamol Rotacaps Salbutamol 200mcg 30’s Rotacaps 13.28
4 Levosalbutamol Rotacaps Levosalbutamol 100mcg 30’s Rotacaps 13.22

--

Each MT Dose contains

--

5 Levosalbutamol Inhaler Levosalbutamol 50mcg 200 MT Dose 59.36

--

Each disk holder contains

--

6 Salbutamol Disk Salbutamol 50mcg as xinafoate 14disk x 4’s Blister 1 disk holder 8.64

--

Each 2.5ml contains

--

7 Salbutamol+ Ambroxol Solutions Salbutamol 2.5mg
Ambroxol HCl – 1.5mg
in isotonic Solution
2.5ml Pack 3.26
8 Salbutamol Solution Salbutamol 2.5mg 2.5ml Pack 3.06
9 Levosalbutamol Solutions Levosalbutamol-0.31mg 2.5ml Pack 2.71
10 Levosalbutamol Solutions Levosalbutamol-0.63mg 2.5ml Pack 3.12
11 Levosalbutamol Solutions Levosalbutamol-1.25mg 2.5ml Pack 3.14
12 Salbutamol + Ipratropium
Bromide Respiratory Solutions
Salbutamol (as Anhydrous)-2.5mg
Ipratropium Bromide 500mcg
2.5ml Pack 3.88
13 Salbutamol +
Budesonide Solutions
Salbutamol 2.5mg
Budesonide – 1mg
2.5ml Pack 4.38

--

Each 5ml contains

--

14 Salbutamol + Etophylline
Syrup
Salbutamol Sulphate eq. to
Salbutamol-1mg
Etophylline 50mg
100ml Bottle 12.40
15 Salbutamol + Etophylline
Syrup
Salbutamol Sulphate eq. to
Salbutamol-2mg
Etophylline 50mg
100ml Bottle 12.66
16 Salbutamol + Ambroxol+
Guaiphenesin Syrup
Salbutamol Sulphate eq. to
Salbutamol-1mg
Ambroxol HCl 30mg
Guaiphenesin 50mg
100ml Bottle 14.80
17 Salbutamol+ Bromohexine HCl
Guaiphenesin Suspension/Syrup
Salbutamol sulphate- 1mg
Bromohexine HCl – 2mg
Guaiphenesin – 25mg
60ml Bottle 8.60
18 Salbutamol+ Bromohexine +
Guaiphenesin Syrup
Salbutamol – 1 mg
Bromohexine – 2mg
Guaiphenesin – 50mg
50ml Bottle 7.66
19 Salbutamol+ Ambroxil HCL+
Guaiphenesin+ Menthol
Syrup/Expectorant
Salbutamol Sulphate 1 mg
Ambroxil HCl – 15mg
Guaiphenesin- 50mg
Menthol – 1mg
60ml Bottle 9.90

--

Each 10ml contains

--

20 Salbutamol + Bromhexime
Guaiphenesin+ Menthol
Syrup
Salbutamol Sulphate eq to
Salbutamol-2mg
Bromhexime Hydrobromide-8mg
Guaiphenesin 100mg
Menthol 0.5mg
100ml Bottle 9.80
21 Salbutamol+ Bromohexine +
Aminochloride + Menthol
Syrup
Salbutamol -2 mg
Bromohexine -4 mg
Aminochloride -100 mg
Menthol -1.5 mg
100ml Bottle 11.70

NOTE :

(a)        The prices fixed are the maximum ceiling prices (exclusive of excise duty and local taxes if any) for the specified pack and packs of similar strength, and companies cannot claim exemption on any ground therefrom, unless specifically permitted by the Government/NPPA through an order.

(b)        Pro-rata pricing for packs of same composition but of different sizes, will be applicable vide S.O. No. 83(E) dated 27.1.1998.

(c)        For different packing material used or any special feature claimed, companies are required to approach NPPA for approval/fixation of specific prices.

PN/87/2006/F

F. No. 8(3)/2006/D.P./NPPA-Div.II

(A. K. PAL)
Deputy Director
National Pharmaceutical Pricing Authority

 

Last Page Updated: 08-06-2019